Form D · Biotechnology
Smart Matrix Ltd
London, X0 · CIK 0001807974
Offering snapshot reported Mar 30, 2020 · SEC filing
- Reported sold
- $444K Offering amount: $14M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Mar 12, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2020 | Initial | $443,703 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $10.4K
- Finders' fees
- $0
- Form D file number
- 021-363885
Total amount sold to US investors = $130,231 USD Total amount sold to non-US investors = ?313,472 USD
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| US Capital Global Securities, LLC | 169544 |
Source: Form D, filed Mar 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Allan | Director |
| Jeremy Curnock Cook | Director |
| Francis Robert Gugen | Director |
| Lilian Hook | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Rd Floor 207 Regent Street
London, X0, W1B 3HH
London, X0, W1B 3HH